McKesson and CoverMyMeds entered the acquisition agreement on Jan. 24. At the time, McKesson said it planned to acquire CoverMyMeds for roughly $1.1 billion, or $0.9 billion net of incremental cash tax benefits.
In January, CoverMyMeds said it would continue to operate as an independent business unit under its existing leadership team after the transaction closed.
More articles on health IT:
McAfee reestablishes as standalone company
AMIA presents 17 health IT policy recommendations on Capitol Hill
3 things C-suite leaders should know before adopting blockchain
